Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,969 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TTF-1 Expression and Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observational Study.
Katayama Y, Yamada T, Morimoto K, Fujii H, Morita S, Tanimura K, Takeda T, Okada A, Shiotsu S, Chihara Y, Hiranuma O, Yamada T, Ota T, Harada T, Hasegawa I, Yoshimura A, Iwasaku M, Tokuda S, Kim YH, Takayama K. Katayama Y, et al. Among authors: fujii h. JTO Clin Res Rep. 2023 Mar 7;4(4):100494. doi: 10.1016/j.jtocrr.2023.100494. eCollection 2023 Apr. JTO Clin Res Rep. 2023. PMID: 37020925 Free PMC article.
Prognostic factors in older patients with wild-type epidermal growth factor receptor advanced non-small cell lung cancer: a multicenter retrospective study.
Seto Y, Kaneko Y, Mouri T, Fujii H, Tanaka S, Shiotsu S, Hiranuma O, Morimoto Y, Iwasaku M, Yamada T, Uchino J, Takayama K. Seto Y, et al. Among authors: fujii h. Transl Lung Cancer Res. 2021 Jan;10(1):193-201. doi: 10.21037/tlcr-20-894. Transl Lung Cancer Res. 2021. PMID: 33569304 Free PMC article.
Analysis of Tumor Heterogeneity Through AXL Activation in Primary Resistance to EGFR Tyrosine Kinase Inhibitors.
Nakamura R, Fujii H, Yamada T, Matsui Y, Yaoi T, Honda M, Tanaka N, Miyagawa-Hayashino A, Yoshimura A, Morimoto K, Iwasaku M, Tokuda S, Kim YH, Konishi E, Itoh K, Takayama K. Nakamura R, et al. Among authors: fujii h. JTO Clin Res Rep. 2023 May 12;4(6):100525. doi: 10.1016/j.jtocrr.2023.100525. eCollection 2023 Jun. JTO Clin Res Rep. 2023. PMID: 37426308 Free PMC article.
Comparing Three Different Anti-Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study.
Katayama Y, Yamada T, Morimoto K, Fujii H, Morita S, Tanimura K, Takeda T, Okada A, Shiotsu S, Chihara Y, Hiranuma O, Yamada T, Ota T, Harada T, Hasegawa I, Iwasaku M, Tokuda S, Tanaka N, Miyagawa-Hayashino A, Takayama K. Katayama Y, et al. Among authors: fujii h. JTO Clin Res Rep. 2024 Jan 30;5(3):100644. doi: 10.1016/j.jtocrr.2024.100644. eCollection 2024 Mar. JTO Clin Res Rep. 2024. PMID: 38444594 Free PMC article.
Risk of Transient Tachypnea of the Newborn following Elective Cesarean Section Increases at a Gestational Age of 37 Weeks Compared to That at ≥ 38 Weeks Despite the Exclusion of Pre-Existing Risk Factors for Neonatal Respiratory Disorders.
Mino Y, Miyahara F, Miura M, Imamoto A, Fujii H, Moriwaki C, Yoshioka K, Namba N. Mino Y, et al. Among authors: fujii h. Yonago Acta Med. 2024 May 11;67(2):150-156. doi: 10.33160/yam.2024.05.009. eCollection 2024 May. Yonago Acta Med. 2024. PMID: 38803593 Free PMC article.
Pseudogout Localized to the Pubic Symphysis.
Nishinarita J, Tsuchida T, Fujii H, Ohira Y. Nishinarita J, et al. Among authors: fujii h. Intern Med. 2024 May 23. doi: 10.2169/internalmedicine.3825-24. Online ahead of print. Intern Med. 2024. PMID: 38777775 Free article. No abstract available.
3,969 results